GlassScriptPhysician profile
Emily C Moore
NPI 1689074668
$1,876.86
in general payments reported to CMS, 2019-2025
19 companies · $350 in 2025
The $350 reported for 2025 was more than what 88% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $413 · 2023: $454 · 2024: $413 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $442.81 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $428.12 | 2022-2025 | Dupixent |
| Abbvie INC. | $214.53 | 2021-2024 | |
| Alcresta Therapeutics, INC. | $164.15 | 2023-2025 | Relizorb |
| Qol Medical, LLC | $121.75 | 2022-2023 | Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $71.98 | 2023-2024 | Gattex |
| Lundbeck LLC | $59.11 | 2022-2025 | Vyepti |
| Nestle Healthcare Nutrition INC. | $54.80 | 2021-2022 | |
| Argenx US, INC. | $52.99 | 2025 | Vyvgart Hytrulo |
| Kyowa Kirin, INC. | $52.21 | 2021 | |
| Mirum Pharmaceuticals, INC. | $37.16 | 2022 | |
| Travere Therapeutics, INC. | $28.77 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $27.29 | 2023 | Kristalose |
| Sanofi-Aventis U.S. LLC | $25.99 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $23.75 | 2024 | Bylvay |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.99 | 2023 | Ozempic |
| Ironwood Pharmaceuticals, INC | $18.87 | 2024 | |
| Albireo Pharma, INC. | $18.67 | 2022 | |
| Pharming Healthcare, INC. | $13.92 | 2023 | Ruconest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.